Keyword Search :
  • Switching Therapies in MS: What Are the Options?

    Clyde E. Markowitz, MD

    Check out this new Neurology Report to learn ways to assess and manage adherence in your patients with MS, monitor disease course through clinical and MRI measures, and make timely treatment adjustments.

    View Activity

  • ADHD Care for African American Adults

    J. Russell Ramsay, PhD

    Get an overview of issues involving the health care system and disparities in care for African American adults, and discover how you can further assess patient and provider cultural biases toward ADHD symptoms and treatment.

    View Activity

  • Barriers to Using Long-Acting Injectable Antipsychotics

    John M. Kane, MD

    LAI antipsychotics are underused in the US. Discover ways to overcome common misconceptions and logistical problems that hinder the use of LAI antipsychotics, and see how leadership and staff buy-in are crucial for implementing this treatment.

    View Activity

  • Differential Diagnosis of Unipolar Vs Bipolar Depression

    Larry Culpepper, MD, MPH

    Do you know the red flags that indicate bipolar disorder in your patients with depression? Review 2 effective tools for screening for bipolar disorder and find out how to use them throughout treatment to recognize manic and hypomanic episodes.

    View Activity


Most Popular


Cultural Issues of Hispanic Patients With ADHD

About two-thirds of Hispanic people in the US may not receive treatment for mental illnesses such as ADHD. This multimedia activity summarizes barriers to Hispanic patients receiving mental health services and practical steps to address these barriers.




Journal CME


Posttraumatic Stress Disorder in the US Veteran Population: Results From the National Health and Resilience in Veterans Study

Robert H. Pietrzak, PhD, MPH (Chair), et al

When you assess veterans' trauma histories, do you include both combat- and noncombat-related traumas? Both types are common. Learn about the prevalence and morbidity of PTSD in veterans and what types of interventions may benefit them.

>>See entire article


CME Partners

Update on Treatment-Resistant Depression: Translating Clinical Science Into Effective Therapies

Michael E. Thase, MD

How do you know if your patients are treatment resistant? In this activity, find out how to categorize treatment-resistant depression, what the risk factors are, and how to recognize and treat it to improve overall outcomes.

>> See entire activity

​​ ​​